Soteria E-View

The Omega Medical Imaging Soteria E-View system is an Image-Intensified Fluoroscopic X-Ray System designed for versatile diagnostic and interventional X-ray imaging in general and pediatric populations. Its regulatory approval for marketing was based on a determination of substantial equivalence to existing devices, supported by non-clinical performance testing that confirmed its technological updates do not introduce new safety or effectiveness concerns, while providing real-time image visualization and integrated radiation safety.

Omega Medical Imaging, LLC has received a determination regarding its Soteria E-View imaging system. This system, identified as an Image-Intensified Fluoroscopic X-Ray System, was reviewed and found to be substantially equivalent to devices already legally marketed. This assessment allows the company to proceed with marketing the Soteria E-View, provided it complies with applicable general controls and regulatory provisions. The Soteria E-View system is intended for use in a variety of radiographic and fluoroscopic applications, including general diagnostic and interventional X-ray imaging for both general and pediatric patient populations. It functions as an interventional fluoroscopic X-ray system, providing real-time image visualization, post-processing capabilities, and integration with radiation safety controls. Although the system incorporates several technological updates compared to its predicate device, the review confirmed that these changes do not introduce new concerns regarding safety or effectiveness, with its equivalence supported by non-clinical performance testing and adherence to relevant safety and quality standards.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific technological updates does the Soteria E-View system incorporate compared to its predicate device, and how do they enhance imaging capabilities or patient safety?; What are the detailed non-clinical performance testing results that supported the determination of substantial equivalence, particularly regarding image quality and radiation dose?; How does the Soteria E-View system's integration with radiation safety controls compare to other commercially available interventional fluoroscopic systems in terms of effectiveness and user interface?; Are there any specific clinical scenarios or patient populations where the Soteria E-View system is expected to offer significant advantages over existing imaging technologies?; What are the ongoing post-market surveillance plans for the Soteria E-View system to ensure long-term safety and effectiveness in diverse clinical settings?